Advertisement

Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – A randomised controlled trial

Published:October 22, 2014DOI:https://doi.org/10.1016/j.numecd.2014.10.007

      Highlights

      • We randomised 50 patients with CFS/ME to receive six months of intermittent high-dose vitamin D or placebo.
      • Vitamin D did not improve pulse-wave velocity or flow-mediated dilatation of the brachial artery compared to placebo.
      • Vitamin D did not improve markers of oxidative stress or inflammation compared to placebo.
      • Vitamin D did not improve symptoms of fatigue compared to placebo.

      Abstract

      Background and aims

      Low 25-hydroxyvitamin D levels are common in patients with chronic fatigue syndrome; such patients also manifest impaired vascular health. We tested whether high-dose intermittent oral vitamin D therapy improved markers of vascular health and fatigue in patients with chronic fatigue syndrome.

      Methods and results

      Parallel-group, double-blind, randomised placebo-controlled trial. Patients with chronic fatigue syndrome according to the Fukuda (1994) and Canadian (2003) criteria were randomised to receive 100,000 units oral vitamin D3 or matching placebo every 2 months for 6 months. The primary outcome was arterial stiffness measured using carotid-femoral pulse wave velocity at 6 months. Secondary outcomes included flow-mediated dilatation of the brachial artery, blood pressure, cholesterol, insulin resistance, markers of inflammation and oxidative stress, and the Piper Fatigue scale.
      As many as 50 participants were randomised; mean age 49 (SD 13) years, mean baseline pulse wave velocity 7.8 m/s (SD 2.3), mean baseline office blood pressure 128/78 (18/12) mmHg and mean baseline 25-hydroxyvitamin D level 46 (18) nmol/L. 25-hydroxyvitamin D levels increased by 22 nmol/L at 6 months in the treatment group relative to placebo. There was no effect of treatment on pulse wave velocity at 6 months (adjusted treatment effect 0.0 m/s; 95% CI −0.6 to 0.6; p = 0.93). No improvement was seen in other vascular and metabolic outcomes, or in the Piper Fatigue scale at 6 months (adjusted treatment effect 0.2 points; 95% CI −0.8 to 1.2; p = 0.73).

      Conclusion

      High-dose oral vitamin D3 did not improve markers of vascular health or fatigue in patients with chronic fatigue syndrome.
      Trial registration: www.controlled-trials.com, ISRCTN59927814.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Nutrition, Metabolism and Cardiovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Spence V.A.
        • Kennedy G.
        • Belch J.J.
        • Hill A.
        • Khan F.
        Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome.
        Clin Sci (Lond). 2008 Apr; 114: 561-566
        • Newton D.J.
        • Kennedy G.
        • Chan K.K.
        • Lang C.C.
        • Belch J.J.
        • Khan F.
        Large and small artery endothelial dysfunction in chronic fatigue syndrome.
        Int J Cardiol. 2012; 154: 335-336
        • Hollingsworth K.G.
        • Hodgson T.
        • Macgowan G.A.
        • Blamire A.M.
        • Newton J.L.
        Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging.
        J Intern Med. 2012 Mar; 271: 264-270
        • Beveridge L.A.
        • Witham M.D.
        Vitamin D and the cardiovascular system.
        Osteoporos Int. 2013; 24: 2167-2180
        • Elamin M.B.
        • Abu Elnour N.O.
        • Elamin K.B.
        • Fatourechi M.M.
        • Alkatib A.A.
        • Almandoz J.P.
        • et al.
        Vitamin d and cardiovascular outcomes: a systematic review and meta-analysis.
        J Clin Endocrinol Metab. 2011; 96: 1931-1942
        • Pittas A.G.
        • Chung M.
        • Trikalinos T.
        • Mitri J.
        • Brendel M.
        • Patel K.
        • et al.
        Systematic review: vitamin D and cardiometabolic outcomes.
        Ann Intern Med. 2010; 152: 307-314
        • Berkovitz S.
        • Ambler G.
        • Jenkins M.
        • Thurgood S.
        Serum 25-hydroxy vitamin D levels in chronic fatigue syndrome: a retrospective survey.
        Int J Vitam Nutr Res. 2009; 79: 250-254
        • Witham M.D.
        • Kennedy G.Y.
        • Belch J.J.F.
        • Hill A.
        • Khan F.
        Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
        Int J Cardiol. 2014; 174: 139-140
        • Reid D.
        • Toole B.J.
        • Knox S.
        • Talwar D.
        • Harten J.
        • O'Reilly D.S.
        • et al.
        The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty.
        Am J Clin Nutr. 2011; 93: 1006-1011
        • Fukuda K.
        • Straus S.E.
        • Hickie I.
        • Sharpe M.C.
        • Dobbins J.G.
        • Komaroff A.
        The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.
        Ann Intern Med. 1994; 121: 953-959
        • Carruthers B.M.
        • Jain A.K.
        • De Meirleir K.L.
        Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols.
        J Chronic Fatigue Sy. 2003; 11: 117
        • Ben-Shlomo Y.
        • Spears M.
        • Boustred C.
        • May M.
        • Anderson S.G.
        • Benjamin E.J.
        • et al.
        Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.
        J Am Coll Cardiol. 2014; 63: 636-646
        • Al Mheid I.
        • Patel R.
        • Murrow J.
        • Morris A.
        • Rahman A.
        • Fike L.
        • et al.
        Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.
        J Am Coll Cardiol. 2011; 58: 186-192
        • Laurent S.
        • Cockcroft J.
        • Van Bortel L.
        • Boutouyrie P.
        • Giannattasio C.
        • Hayoz D.
        • et al.
        Expert consensus document on arterial stiffness: methodological issues and clinical applications.
        Eur Heart J. 2006; 27: 2588-2605
        • Corretti M.C.
        • Anderson T.J.
        • Benjamin E.J.
        • Celermajer D.
        • Charbonneau F.
        • Creager M.A.
        • et al.
        Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.
        J Am Coll Cardiol. 2002; 39: 257-265
        • Piper B.
        Measuring fatigue.
        in: Stromborg M. Olsen J. Instruments for clinical health care research. Jones and Barlett, London1997: 482-496
        • Rodriguez T.
        The challenge of evaluating fatigue.
        J Am Acad Nurse Pract. 2000; 12: 329-338
        • Favrat B.
        • Balck K.
        • Breymann C.
        • Hedenus M.
        • Keller T.
        • Mezzacasa A.
        • et al.
        Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women – PREFER a randomized, placebo-controlled study.
        PLoS One. 2014; 9: e94217
        • Mihrshahi R.
        • Beirman R.
        Aetiology and pathogenesis of chronic fatigue syndrome: a review.
        N Z Med J. 2005; 118: U1780
        • Morris G.
        • Berk M.
        • Galecki P.
        • Maes M.
        The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
        Mol Neurobiol. 2014; 49: 741-756
        • Pedersen B.K.
        The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control.
        Essays Biochem. 2006; 42: 105-117
        • Bischoff-Ferrari H.A.
        • Giovannucci E.
        • Willett W.C.
        • Dietrich T.
        • Dawson-Hughes B.
        Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.
        Am J Clin Nutr. 2006; 84: 18-28
        • Sugden J.A.
        • Davies J.I.
        • Witham M.D.
        • Morris A.D.
        • Struthers A.D.
        Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels.
        Diabet Med. 2008; 25: 320-325
        • Witham M.D.
        • Dove F.J.
        • Dryburgh M.
        • Sugden J.A.
        • Morris A.D.
        • Struthers A.D.
        The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial.
        Diabetologia. 2010; 53: 2112-2119
        • Witham M.D.
        • Dove F.J.
        • Sugden J.A.
        • Doney A.S.
        • Struthers A.D.
        The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial.
        Nutr Metab Cardiovasc Dis. 2012; 22: 864-870
        • Taylor R.R.
        • Jason L.A.
        • Torres A.
        Fatigue rating scales: an empirical comparison.
        Psychol Med. 2000; 30: 849-856
        • Jason L.A.
        • Evans M.
        • Brown M.
        • Porter N.
        • Brown A.
        • Hunnell J.
        • et al.
        Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity.
        Disabil Stud Q. 2011; 31
        • Waterhouse J.C.
        • Perez T.H.
        • Albert P.J.
        Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.
        Ann N Y Acad Sci. 2009; 1173: 757-765
        • Kestenbaum B.
        • Katz R.
        • de Boer I.
        • Hoofnagle A.
        • Sarnak M.J.
        • Shlipak M.G.
        • et al.
        Vitamin D, parathyroid hormone and cardiovascular events among older adults.
        J Am Coll Cardiol. 2011; 58: 1433-1441
        • Saleh F.N.
        • Schirmer H.
        • Sundsfjord J.
        • Jorde R.
        Parathyroid hormone and left ventricular hypertrophy.
        Eur Heart J. 2003; 24: 2054-2060